|
|
||||||||
a Division of Cardiac Surgery, Catholic University, Largo A. Gemelli, 8, Rome, 00168 Italy
b Department of Radiology, University of Rome "Sapienza"-St. Andrea Hospital, Rome, 00168 Italy
(Email: amedeo.anselmi{at}alice.it; carlodececco{at}gmail.com).
In the mid-90s, the potential of cardiac cine-magnetic resonance imaging (MRI) in quantitative and observer-independent assessment of myocardial function were apparent. Initially, assessment of left ventricular function in ischemic heart disease was essentially based on systolic/diastolic wall thickening and contrast enhancement of necrotic myocardium and fibrotic scar. Unfortunately, technical limitations of early scanners (poor sensitivity, competitively inferior diagnostic performance, and long acquisition times) relegated MRI for assessment of ischemic myocardial dysfunction to a research role for several years.
Thanks to technologic improvements, cardiac MRI based on high spatial resolution and tissue characterization now represents the gold standard in the assessment of myocardial function and viability and is superior to single photon emission computed tomography (SPECT) scanning and stress echocardiography. Tissue tagging permits visual analysis of myocardial deformation, but we lack a reliable method to quantify these changes. Modelling/multiparametric strain analysis is expected to overcome the aforementioned limitations and to broaden clinical application. This article [1] represents a landmark advance beyond previous works from this distinguished group that have been important in elucidating the feasibility of the technique.
The importance of this article essentially rests on two points:
Cardiac MRI is a powerful instrument, but cost issues will limit indiscriminate application for all patients with questions regarding myocardial viability. Multiparametric strain analysis is not likely to radically renovate current algorithms for coronary revascularization.
As surgeons, we foresee several purposes beyond the applications for which MRI was initially conceived. Indications for left ventricular reshaping procedures remain under discussion, partly because of our current inability to understand the pathology of left ventricular mechanics in individual patients. Similarly, we cannot predict which patients with functional mitral regurgitation will benefit from a surgically remodelled ventricle. Cardiac MRI with left ventricular finite element strain analysis may eventually guide our decision making for these complex cases. Protean features of remodelled ventricles and the unpredictability of surgical outcomes for heart failure still limit widespread application. Thus, we recognize a tremendous need for reliable tools to stratify candidates and customize operations, and thus overcome the limitations of diagnostic echocardiography. Trials to verify finite element/strain analysis MRI for these scenarios are more than welcome; thus, our collaboration with radiologists should now grow closer and closer.
| References |
|---|
|
|
|---|
Related Article
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |